Why is residual DNA testing a non-negotiable in biomanufacturing? The shift from small molecules to monoclonal antibodies, gene therapies, and vaccines has made biologics the backbone of modern ...

Dublin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Residual DNA Testing Market by Product & Service, Technology, Test Type, Application, End User - Global Forecast to 2030" has been added to ...

(MENAFN- GlobeNewsWire - Nasdaq) Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures ...

What's driving this $370 million transformation? The global residual DNA testing market, valued at US$0.27 billion in 2024, stood at US$0.28 billion in 2025 and is projected to advance at a resilient ...

(MENAFN- GlobeNewsWire - Nasdaq) The residual DNA testing market is set to grow from USD 0.28 billion in 2025 to USD 0.37 billion by 2030, with a 6.0% CAGR. Key factors driving this growth include ...

DUBLIN--(BUSINESS WIRE)--The "Residual DNA Testing Market - A Global and Regional Analysis: Focus on Offering, Test Type, Technology, Application, End User, Country, and Region - Analysis and Forecast ...

Fill out the form below and we'll send your colleague an invitation to the "Addressing Common Misconceptions in Residual Host Cell DNA Testing" event. Residual host cell DNA testing is a critical ...

NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.